Switch Opportunities in the Rx Insomnia Market

Published 12/01/2009

Author: SmartAnalyst

Insomnia is an increasingly common condition, exacerbated by rising stress levels among recession-hit consumers. With many keen to manage their own treatment, it brings a unique opportunity for Rx-to-OTC Switch.

This new guest author report, produced by SmartAnalyst in association with Nicholas Hall & Company, evaluates the prospects for Insomnia providing a concise guide for Rx and OTC marketers keen to pursue this opportunity.


DescriptionCountry LicenceGlobal LicenceBuy Country LicenceBuy Global Licence 
+ Full Report £3,750.00 £4,500.00 Clear